|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.404 SEK | 0.00% |
|
+4.39% | +57.81% |
InDex Pharmaceuticals Holding AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 10.83 million. Revenue was SEK 20.35 million.
Net loss was SEK 3.01 million compared to SEK 41.8 million a year ago. Basic loss per share from continuing operations was SEK 0.01 compared to SEK 0.08 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +57.81% | 19.86M | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
INDEX PHARMACEUTICALS HOLDING AB 